Dr. Hirsch is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3333 Burnet Ave
# ML2003
Cincinnati, OH 45229Phone+1 513-636-4432Fax+1 513-636-3952
Summary
- Dr. Russel Hirsch is a pediatric cardiologist who is director of the Pulmonary Hypertension Program and Co-director of the End-stage Lung Failure Program at Cincinnati Children’s Hospital Medical Center. He received his medical degree from the University of Cape Town in South Africa and completed his residency at St. Louis Children’s Hospital. He then completed fellowships at both St. Louis Children’s Hospital and Washington University School of Medicine. Dr. Hirsch is board certified in Pediatric Cardiology and his clinical interests include hereditary hemorrhagic telangiectasia, pulmonary hypertension, catheterization and intervention, bronchopulmonary dysplasia BPD, and rare lung diseases.
Education & Training
- Washington University/B-JH/SLCH ConsortiumFellowship, Pediatric Cardiology, 1994 - 1997
- University of Cape Town Faculty of MedicineClass of 1988
Certifications & Licensure
- OH State Medical License 2002 - 2026
- IN State Medical License 2019 - 2025
- KY State Medical License 2016 - 2025
- American Board of Pediatrics Pediatric Cardiology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Fellow (FAAP) American Academy of Pediatrics
- Fellow (FACC) American College of Cardiology
Clinical Trials
- Noninvasive Blood Pressure Monitor Evaluation Including Performance During Dysrhythmias Start of enrollment: 2007 Apr 01
- Closure of Muscular Ventricular Septal Defects (VSDs) With the AMPLATZER Muscular VSD (MuVSD) Occluder - Post Approval Study Start of enrollment: 2008 Mar 01
- Closure of Atrial Septal Defects With the AMPLATZER Septal Occluder - Post Approval Study Start of enrollment: 2007 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- 90 citationsProcedure-Type Risk Categories for Pediatric and Congenital Cardiac CatheterizationLisa Bergersen, Kimberlee Gauvreau, Audrey C. Marshall, Jacqueline Kreutzer, Robert H. Beekman
Circulation. Cardiovascular Interventions. 2011-04-01 - 98 citationsCardiac troponin I in pediatrics: Normal values and potential use in the assessment of cardiac injuryRussel Hirsch, Yvonne Landt, Sharon E. Porter, Charles E. Canter, Allan S. Jaffe
The Journal of Pediatrics. 1997-06-01 - 143 citationsComplement blockade for TA-TMA: lessons learned from a large pediatric cohort treated with eculizumabSonata Jodele, Christopher E. Dandoy, Adam Lane, Benjamin L. Laskin, Ashley Teusink-Cross
Blood. 2020-03-26
Professional Memberships
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: